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Abstract
Mesothelioma is one of the most aggressive cancers in the United States
and around the world, with a grim 5-year survival rate of only 8%. After diagnosis
there is little that can be done to stop the progression of the disease. Smoking
has been negatively associated with mesothelioma survival. This may be due to
several factors including increased oxidative stress or sequestration of tobaccorelated carcinogenic compounds by asbestos fibers trapped in the lung. This
study investigated the association between smoking and mesothelioma survival
in the Kentucky population. It examines the risk of living in the low socioeconomic
region of Appalachian Kentucky. This study is a population-based study that
included those diagnosed with mesothelioma as reported by the Kentucky
Cancer Registry (KCR) between 1995 and 2011. The KCR is a Surveillance,
Epidemiology, and End Results (SEER) organization that has maintained gold
standard certification since it was founded. Stage at diagnosis was significantly
associated with survival rate. Cox proportional hazard multivariable model
describing mesothelioma survival from all deaths was separated by stage: early,
late, and unknown. Smoking was strongly associated with late stage
mesothelioma diagnosis with a HR of 1.528 (p = 0.0057). However there was no
significant difference in survival between Appalachian and non-Appalachian
residents. This study suggests that cigarette smoke exposure may decrease
survival of mesothelioma.
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Introduction
Mesothelioma is one of the most aggressive cancers in the United States
and around the world, with a grim 5-year survival rate of only 8%. Mesothelioma
has a long latency period around 30-45 years [2, 3]. After diagnosis there are few
things that can be done to stop the spread of the disease. There are several
treatments that have been known to slow or stop the progression of the disease
after diagnosis; the standard treatments are surgery, radiation, and
chemotherapy. Likewise there are a few lifestyle choices or environmental
exposures that can change the progression of the disease. For example,
smoking, and low socioeconomic status have been negatively associated with
mesothelioma survival, while eating healthy, getting exercise, and having access
to healthcare has been positively associated with mesothelioma survival [4, 5].
The 20th century has seen an increase in mesothelioma incidence [6].
Asbestos is the primary known cause of mesothelioma, though there are
still cases that appear with unknown reasons [7]. Many cases of mesothelioma
are related to occupational exposure. In the 1970s asbestos was banned from
many household and industrial uses [8]. Though the ban is still in place, the
incidence rate of the disease remains high. Asbestos is still present in many,
buildings, ships, piping, automotive and household products [9, 10]. Asbestos
has also been discovered in newly manufactured products imported from abroad
where there are looser regulations on the use of asbestos. The continued use of
asbestos makes mesothelioma an ongoing concern.
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Mesothelioma is a cancer that permeates the mesothelium, which lines
the lungs and chest cavity. The peritoneum may also be affected but the majority
of cases affect the pleural lining of the
lungs. There are three major
hypotheses for the mechanism of
disease reviewed by Toyokuni in 2009
[1]. The major hypotheses are
oxidative stress, chromosome
tangling, and the absorption of
carcinogenic agents.
There are two mechanisms
linking asbestos to oxidative stress.
First, asbestos can contain iron, or
possibly sequester iron that can

Figure 1. This figure outlines three common
hypotheses for the mechanism of asbestos-induced
mesothelioma [1].

catalyze Fenton’s reaction H2O2  OH. Second, when macrophages engulf
asbestos, the particles can puncture the walls of the macrophages causing them
to leak reactive oxygen and other digestive enzymes. For these reasons,
asbestos is thought to produce reactive oxygen species (ROS) [1].
The second hypothesis, chromosome tangling, suggests that asbestos
fibers facilitate the rearrangement of chromosomes during replication.
Chromosome 22 is particularly noted as a hotspot for mutation in mesothelioma.
Chromosomes 1, 3, 6, and 9 are also commonly mutated in mesothelioma [11].
Several studies found the tumor suppressor gene p16 on chromosome 9
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(involved in cell cycle regulation by inhibiting CDKs) was absent in most
mesothelioma cases. The absence of p16 is associated with worse clinical
outcome [12, 13].
A third mechanism of disease commonly hypothesized is that of
adsorption. Asbestos may sequester harmful chemicals for example those found
in cigarettes, or may generate a film of proteins or surfactant. This can cause
harm directly or may attract macrophages and neutrophils to the site, increasing
inflammation and worsening prognosis [1]. There are many harmful chemicals in
tobacco smoke that cause or contribute to lung inflammation and cancer. There
are over 70 known carcinogens in cigarette smoke [14]. Some harmful
constituents include nicotine, which has been observed to increase cell
proliferation, inhibit apoptosis, and increase angiogenesis [15-17]. Acrolein,
acetaldehyde, and formaldehyde are reactive aldehydes that can generate ROS
contributing to oxidative stress [18]. Polyaromatic hydrocarbons can be
metabolized by CYP1A1 or CYP1B1 to reactive intermediates that can cause
DNA damage [19]. Carcinogenic metals like Cd, Ni, Cr, As, and Pb can also be
found in cigarette smoke. These metals contribute to cancer by generation of
reactive oxygen species or contributing to Fenton-like reactions [20].
Smoking has been negatively associated with mesothelioma survival [2123]. This may be due to several factors including increased oxidative stress [24,
25] or sequestration of tobacco related carcinogenic compounds by asbestos
fibers trapped in the lung [1]. This study assessed the association between
smoking and mesothelioma survival in the population of Kentucky.
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Socioeconomic status (SES) has been associated with cancer incidence
and survival [26]. The Appalachian region of Kentucky has 38 distressed
counties which rank in the worst 10% of the nation’s counties [27]. A study was
conducted to analyze socioeconomic status and survival of lung cancer. This
study found that middle-low, middle-high, and highest SES were positively
associated with survival compared with lowest SES with hazard ratios (HR) of
0.96 (95% CI 0.94-.99) 0.92 (95% CI 0.89-0.94) and 0.87 (95% CI 0.84-0.91)
respectively [28]. Poor socioeconomic status has been associated with reduced
mesothelioma survival [4]. For these reasons, living in Appalachian Kentucky
was analyzed as a risk factor for mesothelioma survival in Kentucky.
Kentucky is the state with the highest rate of lung cancer, and is in the top
ten for mesothelioma [29]. The incidence rates of mesothelioma have not
returned to their former levels even after the ban on the use of asbestos.
Smoking is also very common in Kentucky and is thought to increase risk for the
development of mesothelioma [30]. Smoking was identified to negatively impact
survival in lung cancer. One study found a hazard ratio (HR) of 1.38 (95% CI,
1.19-1.60) after adjusting for comorbidities and covariates [31]. Another study
looking at lung function and survival found smoking to be negatively associated
with survival with a HR of 2.29 (95% CI, 1.23-4.26) [22].
This study is a population-based study that associates smoking and
abiding in Appalachian Kentucky with the survival of pleural mesothelioma
patients. There have been previous studies on mesothelioma survival, but this
study is different in that it focuses on the risk of smoking and the progression of
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the disease in a population that is at high risk. Kentucky has the highest rate of
smoking related deaths, the highest smoking rate of those in high school, and is
the nation’s second highest for adult smokers [32].

Material and Methods
This study is a population-based study that includes those diagnosed with
mesothelioma as reported by the Kentucky Cancer Registry (KCR). The KCR is a
Surveillance, Epidemiology, and End Results (SEER) organization that has
maintained gold standard certification since it was founded. The KCR operates in
Kentucky with its headquarters in Lexington, KY. The data was collected and deidentified by the KCR. IRB exempt status was granted for this study.
The KCR reports information gathered from medical records. The
information collected was sufficient for this study. Information included: smoking
status, geographical location, sex, treatment, histology, health insurance, cause
of death, menopause, age, marital status, grade of tumor, stage, and race.
Subjects were followed until death or considered still alive as of May 28, 2013,
which was the last day of follow up in this dataset. Cases diagnosed in Kentucky
from 1998-2011 were used for the study.
The variables used in this study were categorized as follows. Smoking
was categorized as smoker, non-smoker, and unknown status. Location was
described as Appalachian resident, non-Appalachian resident, or unknown. The
Appalachian region in Kentucky is comprised of 54 counties in eastern Kentucky.
The majority of counties in Appalachian Kentucky are distressed having at least
double the national unemployment rate [27]. Age was analyzed as a continuous
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variable. Stage indicated the metastatic progression of the cancer, and was
classified as local, regional, distant, or unknown. Histology described the tissue
affected as epithelial, fibrous, biphasic or unclassified mesothelioma. Healthcare
variables were private insurance, Medicare, Medicaid, uninsured, or unknown.
Female was used as the reference group for gender. Treatments included
surgery, chemotherapy, radiation, or no treatment given by a physician. Marriage
was coded as married (including common law), unmarried, or unknown. Race
was not included as a variable because there were too few black cases; there
were a total of 11 black cases. The final model adjusted variables include: marital
status, insurance, Appalachian, site, treatment, stage, and age. These
adjustments were decided beforehand to reduce variability and possible bias in
comparisons.
All analyses were conducted using SAS 9.3. Kaplan-Meier curves were
generated to show the survival rates and Cox regression analyses were
performed for the hazard analysis. The data was analyzed unadjusted and
adjusted for age, stage, treatment, site, marriage, and insurance type. The
information was separated into stages as well because stage at diagnosis played
an important roll in survivability. The study reports the total number of deaths
after diagnosis.
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Results
From the incidence demographics in table one several observations can
be made. First mesothelioma appears to mostly affect white males. Smokers
have a much higher percent distribution than non-smokers. Mesothelioma is
normally discovered later in life, and the majority of cases are metastatic with
distant colony formation. Finally, there are several common treatment options,
chemotherapy being the most commonly administered. Table one provides the
basic details of the study population and shows differences between Appalachian
and non-Appalachian residents.
Table 1: Demographics of Appalachian and Non-Appalachian Populations
Total
Demographics of
Population at Risk
Age
20-49
50-64
65-74
75+
Average Age
Sex
Male
Female
Race
White/other
Black
Smoking
Non-smoker
Smoker
Unknown
Insurance
None
Private
Medicaid
Medicare
Unknown
Site
Unspecified
Fibrous
Epithelioid
Biphasic

Appalachian

N

%

N

%

NonAppalachian.
N
%

434

100

119

27.4

315

72.6

38
103
139
154
68.6 years

8.8
23.7
32
35.5

12
32
37
38

10.1
26.9
31.1
31.9

26
71
102
116

8.3
22.5
32.4
36.8

322
112

74.2
25.8

88
31

74.0
26.1

234
81

74.3
25.7

423
11

97.5
2.5

118
1

99.2
0.8

305
10

96.8
3.2

113
258
63

26
59.5
14.5

21
78
20

17.7
65.6
16.8

92
180
43

29.2
57.1
13.7

7
115
14
287
11

1.6
26.5
3.2
66.1
2.5

2
27
7
77
6

1.7
22.7
5.9
64.7
5.0

5
88
7
210
5

1.6
27.9
2.2
66.7
1.6

262
34
109
29

60.4
7.8
25.1
6.7

78
10
24
7

65.6
8.4
20.2
5.9

184
24
85
22

58.4
7.6
27.0
7.0
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Stage
Localized
Regional
Distant
Unknown
Treatment
Surgery
Chemo
Radiation

73
84
197
80

16.8
19.4
45.4
18.4

16
23
56
24

13.5
19.3
47.1
20.2

57
61
141
56

18.1
19.4
44.8
17.8

109
169
67

25.1
38.9
15.4

34
43
17

28.6
36.1
14.3

75
126
50

23.8
40.0
15.9

Table two provides unadjusted and adjusted Cox Proportional Hazard
Ratios (HR) for those who died after mesothelioma diagnosis from all causes. In
this analysis smoking was significantly linked with poor survival with an adjusted
HR of 1.448 (95% CI 1.14-1.84). The adjusted HR accounted for marital status,
insurance, Appalachian, site, treatment, stage, and age. The crude death rate
was calculated as the number of deaths by all causes divided by the number
diagnosed multiplied by 100%. The next column shows the five-year survival rate
post diagnosis. Other factors that played a significant role in survival were age,
sex, treatment and site. Though there were differences in survival between
Appalachian and non-Appalachian residents, these observations were not
statistically significant.
Table 2: All Cause Unadjusted and Adjusted Survival Analysis of
Mesothelioma Diagnoses from 1995 to 2011 as reported by the Kentucky
Cancer Registry
No. at
Risk
All Cases
Age
Continuous
Sex
Male
Female
Smoking
Non-Smoking
Smoking
Unknown
Appalachian
Non-Appalachian

Unadjusted HR
(95% CI)

434

No.
Death Rate 5-Year
Deaths by
Rate
All Cause
402
92.6%
0.871

Adjusted HR (95%
CI)

434

402

92.6%

0.811

1.031 (1.02-1.04) 1.030 (1.02-1.04)

322
112

309
93

96.0%
83.1%

0.864
0.658

1.680 (1.33-2.13) 1.494 (1.17-1.90)
1 (REF)
1 (REF)

113
258
63

102
243
57

90.3%
94.2%
90.5%

0.738
0.842
0.816

1 (REF)
1 (REF)
1.281 (1.02-1.62) 1.448 (1.14-1.84)
1.274 (0.92-1.76) 1.259 (0.91-1.75)

315

294

93.3%

0.817

1 (REF)

1 (REF)
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Appalachian
119
108
90.8%
0.795
0.998 (0.80-1.25)
Treatment
Surgery
109
91
83.5%
0.639
1 (REF)
1.409 (1.06-1.87)
Chemo
113
104
92.0%
0.823
1.764 (1.15-2.70)
Radiation
28
28
100%
0.857
2.282 (1.76-2.95)
No Treatment
184
179
97.3%
0.899
Site
Epithelioid
109
96
88.1%
0.729
1 (REF)
1.857 (1.25-2.77)
Fibrous
34
33
97.1%
0.912
2.279 (1.48-3.50)
Biphasic
29
27
93.1%
0.947
Unspecified
262
246
93.9%
0.817
1.230 (0.97-1.56)
Insurance
Private
115
95
82.6%
0.739
1 (REF)
Medicaid
14
11
78.6%
0.519
1.088 (0.58-2.04)
Medicare
287
280
97.6%
0.863
1.800 (1.42-2.28)
Not Insured
7
5
71.4%
0.571
0.775 (0.31-1.91)
Unknown
11
11
100%
0.727
1.637 (0.88-3.06)
Marital Status
Married
188
171
91.0%
0.831
1 (REF)
Unmarried
95
88
92.6%
0.787
1.064 (0.82-1.38)
Unknown
151
143
94.7%
0.801
0.968 (0.75-1.21)
*Adjusted for marital status, insurance, Appalachian, site, treatment, stage, and age

1.053 (0.84-1.32)
1 (REF)
1.276 (0.96-1.70)
1.258 (0.80-1.98)
1.817 (1.37-2.42)
1 (REF)
1.657 (1.10-2.49)
2.576 (1.67-3.98)
1.409 (1.10-1.81)
1 (REF)
1.331 (0.70-2.53)
0.941 (0.68-1.31)
1.181 (0.48-2.94)
1.166 (0.59-2.30)
1 (REF)
0.868 (0.65-1.12)
1.041 (0.81-1.34)

It was important to stratify the data by stage because of the large impact
stage at diagnosis plays in overall survival. Table 3 shows Cox Proportional
Hazard multivariable models describing mesothelioma survival from all deaths
separated by stages: early, late, and unknown. Smoking with a late stage
mesothelioma diagnosis was negatively associated with survival with a HR of
1.528 (p = 0.0057). Other pronounced associations in this analysis were no
treatment having an adjusted HR of 1.986 (p < .0001), and sites fibrous and
biphasic with adjusted HRs of 2.891 (p < .0001) and 3.153 (p < .0001)
respectively. However, Appalachian residency remained statistically insignificant
for all stages at diagnosis.
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Table 3: Adjusted Analysis by Stage at Diagnosis among those Diagnosed
with Mesothelioma from 1995 to 2011 as Reported by the Kentucky Cancer
Registry
Early Stage N=73
All Cause
Death Rate

Late Stage N=281

Unknown Stage N=80

Adjusted HRƗ All Cause Adjusted HRƗ All Cause
(p value)
Death Rate (p value)
Death Rate

Age
1.032 (0.0389)
1.023 (0.0005)
Continuous
Sex
1.414 (0.0232) 0.983
Male
.964
1.799 (0.1061) 0.951
Female
.824
1 (REF)
0.867
1 (REF)
0.700
Smoking
Non-Smoking
0.722
1 (REF)
0.908
1 (REF)
0.895
1.528 (0.0057) 0.956
Smoking
0.932
1.001 (0.9987) 0.941
Unknown
1
1.109 (0.8114) 0.917
1.283 (0.2468) 0.813
Appalachian
Non-Appalachian 0.930
1 (REF)
0.946
1 (REF)
0.893
Appalachian
0.938
1.072 (0.8409) 0.886
1.059 (0.6932) 0.958
Treatment
Surgery
0.778
1 (REF)
0.971
1 (REF)
0.615
Chemo
1
0.901 (0.7952) 0.885
1.275 (0.1589) 0.929
Radiation
1
0.454 (0.2342) 0.900
1.717 (0.0445) 1
1.986 (<.0001) 0.980
No Treatment
0.968
0.926 (0.8532) 0.971
Site
Epithelioid
1
1 (REF)
0.861
1 (REF)
0.867
0.221 (0.0249) 0.962
2.891 (<.0001) 1
Fibrous
1
3.153 (<.0001) 1
Biphasic
0.857
1.281 (0.6313) 0.947
1.663 (0.0008) 0.915
Unspecified
0.913
0.598 (0.1562) 0.955
Insurance
Private
0.750
1 (REF)
0.859
1 (REF)
0.765
Medicaid
1
1.391
0.857
1.812 (0.1761) 0.600
Medicare
1
1.099
0.963
0.871 (0.4855) 1
Not Insured
N/A
N/A
0.750
1.193 (0.7663) 0.667
Unknown
1
2.632
1
1.573 (0.4617) 1
Marital Status
Married
0.931
1 (REF)
0.922
1 (REF)
0.636
Unmarried
0.943
0.496 (0.0743) 0.943
0.987 (0.9328) 0.818
Unknown
0.914
0.760 (0.3439) 0.931
0.992 (0.9631) 0.983
*Adjusted for marital status, insurance, Appalachian, site, treatment, stage, and age

Adjusted HRƗ
(p value)
1.052 (<.0001)
1.589 (0.1806)
1 (REF)
1 (REF)
1.700 (0.0880)
1.861 (0.1235)
1 (REF)
0.791 (0.3994)
1 (REF)
1.454 (0.4607)
1.128 (0.8691)
2.311 (0.0548)
1 (REF)
0.582 (0.4141)
3.000 (0.1166)
0.952 (0.8872)
1 (REF)
0.955 (0.9472)
0.570 (0.2147)
0.619 (0.6572)
0.657 (0.4510)
1 (REF)
0.712 (0.5946)
1.722 (0.2641)
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Smokers and Non-Smokers Survival in Kentucky from 1994-2011

Figure 2. The survival curve for smoking illustrates that smokers had a significantly reduced
survival rate compared with non-smokers. The difference is most pronounced in the first 50
months post diagnosis.

Appalachian and Non-Appalachian Survival in Kentucky from 1994-2011

Figure 3. There was very little change between the survival curves from Appalachian and non-Appalachian
Kentucky.
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Discussion
Through this study smoking can be strongly associated with mesothelioma
survival. Smoking status had the most dramatic effect on survival for late stage
patients with a hazard ratio of 1.528 (p = 0.0057). The data indicate that smoking
is more significantly associated with survival than many other risk factors. These
findings suggest those who do not smoke will have significantly increased
survival. Those in high-risk occupations may benefit greatly from smoking
counseling and cessation programs prior to disease onset.
Smoking is both statistically significant and practically significant. The
study found non-smokers’ survival probability at 24 months is close to 40% while
smokers’ survival probability is close to 20%. This can be seen in the KaplanMeier curve in Figure 2. This survival probability gap becomes smaller as we
approach the 5-year mark. Since mesothelioma is a very fast acting cancer once
diagnosed, both smoking and non-smoking have very low survival probability
after 5 years.
Several studies have observed similar hazard ratios when examining
smoking and lung cancer. In 2003, Tammemagi et al. found a HR of 1.38
(p>0.001) for smokers compared with non-smokers. Moshammer et al. in 2009
found an HR of 2.89, while Naomi et al. in 2014 found an HR or 1.39. These
results support our findings that smoking decreases survival after mesothelioma
diagnosis. The difference between our study and these studies is that we looked
at mesothelioma specifically while these other studies reported lung cancers
generally. Additionally this study is more accurate than previous studies because
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it analyzes a population while previous studies reported survival ratios based on
fewer cases.
Comparing Appalachian Kentucky with non-Appalachian Kentucky did not
yield any significant change in survival after adjustment for smoking and other
significant risk factors. The results suggest that there may be little genetic
predisposition for mesothelioma survival in those who are living in Appalachian
Kentucky. It indicates that socioeconomic factors in Appalachia may need to be
better defined rather than analyzing at a county level. Additionally, it is important
to note that there are more smokers in Appalachian Kentucky. It still may be
beneficial to focus smoking cessation programs in this area to extend cancer
survival.
A major strength of this study is that it is a population-based study. The
data for this study represents all cancer cases from the state of Kentucky from
1995 to 2011. However, since mesothelioma is a relatively rare disease there
were only 434 cases during this long time period. For example, there were only
14 cases holding Medicaid insurance, and only 28 cases received radiation. Most
other variables had many cases, which increase the predictive power. Smoking
status was well defined with 113 cases in non-smokers and 258 in smokers. To
improve some of the lower variables like Medicaid insurance and radiation
treatment, a national study may be conducted.
Some additional information on patients may provide further
understanding on mesothelioma survival in the future. For example, exercise
data was not included in this study. People with a history of regular exercise may
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exhibit a better survival outcome for mesothelioma. It may be helpful in future
studies to include a short exercise questionnaire as a part of the cancer data
collection. Exercise has been shown in several studies to reduce cancer risk [33].
Additionally, a review showed exercise was correlated with improved survival, but
smoking was not accounted for in that review [34]. The inclusion of exercise data
may be a significant addition for mesothelioma survival studies in the future.
The second additional piece of information that may prove useful in future
studies is nutritional data. People with a history consuming foods high in
antioxidants may have higher survival rates. Some studies indicate nutrition plays
a valuable role in cancer incidence and progression for many different cancer
types. Foods high in antioxidants have been suggested to lower cancer risk while
red meats, refined foods, and regular or high alcohol consumption have been
shown to increase risk [35-37].
In conclusion, these data suggest that smoking is a risk factor associated
with reducing mesothelioma survivability. The data collected from the Kentucky
Cancer Registry is consistent with reports in the literature for smoking and lung
cancer survival. Further research is needed in this area to better understand this
association.
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